The age of genomic profiling

Identifying BRCA mutations for breast and ovarian cancer

Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause in breast cancer survivors

What should be the HPV vaccine strategy for India?

Niraparib therapy in patients with newly diagnosed advanced ovarian cancer

ARIEL3: Rucaparib maintenance treatment for recurrent ovarian carcinoma

Highlights from ESMO 2019

Ovarian highlights from ESMO 2019

VELIA/GOG-3005 trial: Veliparib for high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin

More ovarian cancer patients benefit from maintenance combined targeted therapy

Comment: PARP inhibitor olaparib plus bevacizumab in women with ovarian cancer

PARP inhibitor olaparib added to bevacizumab benefits women with ovarian cancer with and without a BRCA mutation